Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does 10-HYDROXYCAMPTOTHECIN Cause Post embolisation syndrome? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Post embolisation syndrome have been filed in association with 10-HYDROXYCAMPTOTHECIN. This represents 60.6% of all adverse event reports for 10-HYDROXYCAMPTOTHECIN.

20
Reports of Post embolisation syndrome with 10-HYDROXYCAMPTOTHECIN
60.6%
of all 10-HYDROXYCAMPTOTHECIN reports
4
Deaths
0
Hospitalizations

How Dangerous Is Post embolisation syndrome From 10-HYDROXYCAMPTOTHECIN?

Of the 20 reports, 4 (20.0%) resulted in death.

Is Post embolisation syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for 10-HYDROXYCAMPTOTHECIN. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does 10-HYDROXYCAMPTOTHECIN Cause?

Device use issue (20) Off label use (20)

What Other Drugs Cause Post embolisation syndrome?

EPIRUBICIN (31) DOXORUBICIN (26) ETHIODIZED OIL (24) GELATIN (21) IODIZED OIL (21) OXALIPLATIN (11) BEVACIZUMAB (6) MITOMYCIN (6) CAMRELIZUMAB (5)

Related Pages

10-HYDROXYCAMPTOTHECIN Full Profile All Post embolisation syndrome Reports All Drugs Causing Post embolisation syndrome 10-HYDROXYCAMPTOTHECIN Demographics